Digital therapeutics

Software that functions as a medical device

Prescription digital therapeutics address the sleep and anxiety symptoms that follow mTBI — deployed alongside monitoring, so their effect is measured rather than assumed.

What SaMD means

A therapy delivered as software

Software as a Medical Device is exactly what it sounds like: a clinically validated intervention whose delivery mechanism is an application rather than a pill or a procedure. It is prescribed, its use is monitored, and its effect is measured.

Why it belongs in a monitoring program: sleep disruption and anxiety are among the most persistent post-concussive symptoms, and both are highly responsive to structured behavioural intervention. Because we are already capturing sleep stages, HRV and mood daily, we can see whether the intervention is working within weeks instead of waiting for the next appointment.

Targets

What these programs address

Sleep

Structured programs for insomnia and disrupted sleep architecture — tracked against the sleep-stage data we already collect.

Anxiety

Guided behavioural intervention for the anxiety that affects 15–50% of people after an mTBI.

Mood

Daily mood tracking that feeds the same care-team review as every other monitored signal.

Independence

A note on our partners

NeuroGlympse contracts with third parties for anonymized treatment metrics and works with technology partners for data collection. We are not affiliated with those organisations beyond those contracted arrangements, and clinical interpretation remains ours alone.

Ask what is available for your patients

Availability varies by indication and jurisdiction. Our team can tell you what applies to your case.

Call usEnroll a patient